Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 357

2.

Seeing is believing: visualization of transcriptional activity of p53.

Sun Y.

Cancer Biol Ther. 2003 Mar-Apr;2(2):203-5. No abstract available.

PMID:
12750564
3.

The p53-inhibitor pifithrin-alpha inhibits firefly luciferase activity in vivo and in vitro.

Rocha S, Campbell KJ, Roche KC, Perkins ND.

BMC Mol Biol. 2003 Sep 11;4:9.

4.
5.

A novel bioluminescent tumor model of human renal cancer cell lines: an in vitro and in vivo characterization.

Peter C, Kielstein JT, Clarke-Katzenberg R, Adams MC, Pitsiouni M, Kambham N, Karimi MA, Kengatharan KM, Cooke JP.

J Urol. 2007 Jun;177(6):2342-6.

PMID:
17509355
6.
7.
8.

A transgenic mouse model with a luciferase reporter for studying in vivo transcriptional regulation of the human CYP3A4 gene.

Zhang W, Purchio AF, Chen K, Wu J, Lu L, Coffee R, Contag PR, West DB.

Drug Metab Dispos. 2003 Aug;31(8):1054-64.

9.

In vitro validation of bioluminescent monitoring of disease progression and therapeutic response in leukaemia model animals.

Inoue Y, Tojo A, Sekine R, Soda Y, Kobayashi S, Nomura A, Izawa K, Kitamura T, Okubo T, Ohtomo K.

Eur J Nucl Med Mol Imaging. 2006 May;33(5):557-65.

PMID:
16501974
10.

Bioluminescent detection of endotoxin effects on HIV-1 LTR-driven transcription in vivo.

Yull FE, Han W, Jansen ED, Everhart MB, Sadikot RT, Christman JW, Blackwell TS.

J Histochem Cytochem. 2003 Jun;51(6):741-9.

PMID:
12754285
11.

Optical imaging of luminescence for in vivo quantification of gene electrotransfer in mouse muscle and knee.

Bloquel C, Trollet C, Pradines E, Seguin J, Scherman D, Bureau MF.

BMC Biotechnol. 2006 Mar 8;6:16.

12.
13.

In vivo bioluminescent imaging of virus-mediated gene transfer and transduced cell transplantation in the intervertebral disc.

Leo BM, Li X, Balian G, Anderson DG.

Spine (Phila Pa 1976). 2004 Apr 15;29(8):838-44.

PMID:
15082981
15.

In vivo bioluminescence imaging of murine xenograft cancer models with a red-shifted thermostable luciferase.

Mezzanotte L, Fazzina R, Michelini E, Tonelli R, Pession A, Branchini B, Roda A.

Mol Imaging Biol. 2010 Aug;12(4):406-14. doi: 10.1007/s11307-009-0291-3. Epub 2009 Nov 25.

PMID:
19937390
16.

Noninvasive of adenovirus tumor retargeting in living subjects by a soluble adenovirus receptor-epidermal growth factor (sCAR-EGF) fusion protein.

Liang Q, Dmitriev I, Kashentseva E, Curiel DT, Herschman HR.

Mol Imaging Biol. 2004 Nov-Dec;6(6):385-94.

PMID:
15564149
17.

Real-time imaging of TRAIL-induced apoptosis of glioma tumors in vivo.

Shah K, Tang Y, Breakefield X, Weissleder R.

Oncogene. 2003 Oct 9;22(44):6865-72.

PMID:
14534533
18.

Visualization of endogenous p53-mediated transcription in vivo using sodium iodide symporter.

Kim KI, Chung JK, Kang JH, Lee YJ, Shin JH, Oh HJ, Jeong JM, Lee DS, Lee MC.

Clin Cancer Res. 2005 Jan 1;11(1):123-8.

19.

ABCG2/BCRP expression modulates D-Luciferin based bioluminescence imaging.

Zhang Y, Bressler JP, Neal J, Lal B, Bhang HE, Laterra J, Pomper MG.

Cancer Res. 2007 Oct 1;67(19):9389-97.

20.

Quantitative analysis of p53-targeted gene expression and visualization of p53 transcriptional activity following intratumoral administration of adenoviral p53 in vivo.

Ohtani S, Kagawa S, Tango Y, Umeoka T, Tokunaga N, Tsunemitsu Y, Roth JA, Taya Y, Tanaka N, Fujiwara T.

Mol Cancer Ther. 2004 Jan;3(1):93-100.

Items per page

Supplemental Content

Write to the Help Desk